{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:54:31Z","timestamp":1773161671634,"version":"3.50.1"},"reference-count":41,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>While not a specific disease, dementia is a term used to describe the deterioration of cognitive function beyond what would be expected because of natural biological aging [...]<\/jats:p>","DOI":"10.3390\/ijms24097996","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T04:36:15Z","timestamp":1682656575000},"page":"7996","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular, Translational and Clinical Research on the Two Most Common Forms of Neurodegenerative Dementia: Alzheimer\u2019s Disease and Dementia with Lewy Bodies"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8808-4242","authenticated-orcid":false,"given":"Eleonora","family":"Napoli","sequence":"first","affiliation":[{"name":"Department of Neurology, University of California Davis School of Medicine, Sacramento, CA 95817, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association Publishing. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_2","unstructured":"World Health Organization (2023, April 01). Fact Sheets of Dementia. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/postgradmedj-2020-138517","article-title":"Early-onset dementia: Key issues using a relationship-centred care approach","volume":"97","author":"Nwadiugwu","year":"2021","journal-title":"Postgrad. Med. J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/WNL.0000000000003162","article-title":"The terrorist inside my husband\u2019s brain","volume":"87","author":"Williams","year":"2016","journal-title":"Neurology"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bandopadhyay, R., Gatt, A., and Lashley, T. (2023). Advances in the Understanding of Frontotemporal Dementia. Cells, 12.","DOI":"10.3390\/cells12050781"},{"key":"ref_7","unstructured":"Blum, D. (2023, February 16). Bruce Willis Has Frontotemporal Dementia, His Family Announces. Available online: https:\/\/www.nytimes.com\/2023\/02\/16\/well\/mind\/bruce-willis-frontotemporal-dementia-aphasia.html."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/jamaneurol.2021.2161","article-title":"Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis","volume":"78","author":"Hendriks","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/gps.2439","article-title":"Impact of early onset dementia on caregivers: A review","volume":"25","author":"Bakker","year":"2010","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/gps.4430","article-title":"Time to diagnosis in young-onset dementia and its determinants: The INSPIRED study","volume":"31","author":"Draper","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chan, H.J., Roy, J., Tipoe, G.L., Fung, M.L., and Lim, L.W. (2021). Therapeutic Potential of Human Stem Cell Implantation in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221810151"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Jantrapirom, S., Nimlamool, W., Chattipakorn, N., Chattipakorn, S., Temviriyanukul, P., Inthachat, W., Govitrapong, P., and Potikanond, S. (2020). Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051725"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Moreira, G.G., Cristovao, J.S., Torres, V.M., Carapeto, A.P., Rodrigues, M.S., Landrieu, I., Cordeiro, C., and Gomes, C.M. (2019). Zinc Binding to Tau Influences Aggregation Kinetics and Oligomer Distribution. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20235979"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Roy, J., Tsui, K.C., Ng, J., Fung, M.L., and Lim, L.W. (2021). Regulation of Melatonin and Neurotransmission in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136841"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Toledo, A.R.L., Monroy, G.R., Salazar, F.E., Lee, J.Y., Jain, S., Yadav, H., and Borlongan, C.V. (2022). Gut-Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031184"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Yu, H., Zhang, C., Xia, J., and Xu, B. (2021). Treadmill Exercise Ameliorates Adult Hippocampal Neurogenesis Possibly by Adjusting the APP Proteolytic Pathway in APP\/PS1 Transgenic Mice. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179570"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Lachen-Montes, M., Mendizuri, N., Schvartz, D., Fernandez-Irigoyen, J., Sanchez, J.C., and Santamaria, E. (2020). Proteomic Characterization of the Olfactory Molecular Imbalance in Dementia with Lewy Bodies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176371"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Wang, J., Napoli, E., Kim, K., McLennan, Y.A., Hagerman, R.J., and Giulivi, C. (2021). Brain Atrophy and White Matter Damage Linked to Peripheral Bioenergetic Deficits in the Neurodegenerative Disease FXTAS. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22179171"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Brown, J., Park, Y.J., Lee, J.Y., Chase, T.N., Koga, M., and Borlongan, C.V. (2020). Bone Marrow-Derived NCS-01 Cells Advance a Novel Cell-Based Therapy for Stroke. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082845"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Choi, I.A., Yun, J.H., Kim, J.H., Kim, H.Y., Choi, D.H., and Lee, J. (2019). Sequential Transcriptome Changes in the Penumbra after Ischemic Stroke. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246349"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Gugliandolo, A., Bramanti, P., and Mazzon, E. (2020). Activation of Nrf2 by Natural Bioactive Compounds: A Promising Approach for Stroke?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21144875"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Huang, J., Lyu, H., Huo, K., Do Prado, L.B., Tang, C., Wang, Z., Li, Q., Wong, J., and Su, H. (2020). Bone Fracture Enhanced Blood-Brain Barrier Breakdown in the Hippocampus and White Matter Damage of Stroke Mice. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228481"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bbadis.2016.01.015","article-title":"Stroke injury, cognitive impairment and vascular dementia","volume":"1862","author":"Kalaria","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1590\/S1980-57642010DN40100014","article-title":"Dementia in Fragile X-associated Tremor\/Ataxia Syndrome","volume":"4","author":"Nitrini","year":"2010","journal-title":"Dement Neuropsychol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Salcedo-Arellano, M.J., Sanchez, D., Wang, J.Y., McLennan, Y.A., Clark, C.J., Juarez, P., Schneider, A., Tassone, F., Hagerman, R.J., and Martinez-Cerdeno, V. (2021). Case Report: Coexistence of Alzheimer-Type Neuropathology in Fragile X-Associated Tremor Ataxia Syndrome. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.720253"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/ajmg.b.30732","article-title":"Dementia in fragile X-associated tremor\/ataxia syndrome (FXTAS): Comparison with Alzheimer\u2019s disease","volume":"147B","author":"Seritan","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archneurol.2007.30","article-title":"Fragile X-associated tremor\/ataxia syndrome: An aging face of the fragile X gene","volume":"65","author":"Amiri","year":"2008","journal-title":"Arch. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/CIRCRESAHA.122.319951","article-title":"Post-Stroke Cognitive Impairment and Dementia","volume":"130","author":"Rost","year":"2022","journal-title":"Circ. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Madokoro, Y., Yoshino, Y., Kato, D., Sato, T., Mizuno, M., Kanamori, T., Shimazawa, M., Hida, H., Hara, H., and Yoshida, M. (2019). Reduced Cholinergic Activity in the Hippocampus of Hippocampal Cholinergic Neurostimulating Peptide Precursor Protein Knockout Mice. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215367"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.31887\/DCNS.2004.6.3\/imckeith","article-title":"Dementia with Lewy bodies","volume":"6","author":"McKeith","year":"2004","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/WNL.53.9.2003","article-title":"Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies","volume":"53","author":"Growdon","year":"1999","journal-title":"Neurology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/WAD.0b013e318065c4a9","article-title":"Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease","volume":"21","author":"Bostrom","year":"2007","journal-title":"Alzheimer. Dis. Assoc. Disord."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/gps.1738","article-title":"Patients with Lewy body dementia use more resources than those with Alzheimer\u2019s disease","volume":"22","author":"Bostrom","year":"2007","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1212\/01.wnl.0000247041.63081.98","article-title":"Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease","volume":"67","author":"Williams","year":"2006","journal-title":"Neurology"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Baker, M. (2008). Mis-oriented stem cells don\u2019t divide. Nat. Rep. Stem Cells.","DOI":"10.1038\/stemcells.2008.139"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1242\/dmm.003137","article-title":"Potential and pitfalls of stem cell therapy in old age","volume":"3","author":"Piccin","year":"2010","journal-title":"Dis. Model Mech."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1212\/WNL.0000000000012451","article-title":"Aducanumab, Amyloid Lowering, and Slowing of Alzheimer Disease","volume":"97","author":"Salloway","year":"2021","journal-title":"Neurology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer\u2019s Disease","volume":"388","author":"Swanson","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/d41586-023-00030-3","article-title":"FDA approves Alzheimer\u2019s drug lecanemab amid safety concerns","volume":"613","author":"Reardon","year":"2023","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Steinbrook, R. (2021). The Accelerated Approval of Aducanumab for Treatment of Patients With Alzheimer Disease. JAMA Intern. Med., 181.","DOI":"10.1001\/jamainternmed.2021.4622"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in Early Alzheimer\u2019s Disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/9\/7996\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:25:24Z","timestamp":1760124324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/9\/7996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["ijms24097996"],"URL":"https:\/\/doi.org\/10.3390\/ijms24097996","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]}}}